Delivery Order SPE2DB22D2108-SPE2DB24FU2WK
Award Date 12/7/23
Potential Completion Date 12/8/23
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,686.54, is for the delivery of Estrogen-Methyltestos H.S. Tablets in quantities of 100s. This is a Firm Fixed Price Delivery Order contract with a completion date of September 27, 2023. The contract was awarded on September 26, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $1,661.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for "ESTROGEN-METHYLTESTOS F.S. TAB 100S" and has an ultimate completion date of August 28, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is part of a larger...
- This federal contract award, valued at $1,752.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a medical product, with a completion date of November 13, 2023. The contract is a Firm Fixed Price (FFP) arrangement and was not designated with a set-aside requirement, indicating open...
- This federal contract award, valued at $4,513.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4554831927 - ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of September 21, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $1,157.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, and is classified as a Firm Fixed Price Delivery Order with a completion date of July 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of pharmaceutical products, including Estrogen-Methyltestos F.S. tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,792.32 and a completion date of September 25, 2023. It is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with a set-aside requirement, indicating it...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $2,244.70 firm fixed-price delivery order is for the supply of Estrogen-Methyltestos F.S. Tablets in 100-count packages. This award is not associated with a set-aside program and has a completion date of July 19, 2024. Amerisourcebergen, as a prime contractor, has previously been awarded multiple Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Estrogen-Methyltestosterone tablets. The $1,201.82 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,581.74 firm fixed-price delivery order is for the supply of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a medical commodity. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,316.14, is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has a completion date of September 10, 2021. The contract is not designated with a set-aside requirement, indicating open...